Clovis Oncology Stock News

Clene Inc. (CLNN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Clovis (CLVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

In recent weeks, the stock market has stabilized after June's sell-off, but it may take time before bullishness makes a comeback. Plenty of uncertainty remains, including further interest rate hikes,

BOULDER, Colo.--(BUSINESS WIRE)---- $CLVS--First paragraph, second sentence of release should read: Clovis' senior management will host a conference call and live audio webcast at 8:30am ET to discuss

BOULDER, Colo.--(BUSINESS WIRE)---- $CLVS--Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its second quarter 2022 financial results and provide an update on its clinical development programs and r

Investors were cheered by news of a freshly signed supply deal.

Investors were cheered by news of a freshly signed supply deal.

CLVS stock is rallying 7% after Clovis Oncology made a major deal with NorthStar Medical. Takeover speculation has swirled around Clovis.

After a massive surge in its share price recently, Clovis Oncology has started to reverse course.

After a massive surge in its share price recently, Clovis Oncology has started to reverse course.

Clovis Oncology has recently been on a winning streak of clinical data and corporate updates. As a result, the share price has rocketed off its 52-week lows. The company's theranostic FAP was able to

Biotech stocks are back in favor as some risk-on activity permeates the broader market. Clovis Oncology (CLVS) shares spiked from under 50 cents to above $3 recently as news about its key drugs stirs

Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board recomme

U.S. stocks traded slightly higher toward the end of trading as investors digested the recent jobs report for the month of June. The Dow traded up 0.24% to 31,460 while the NASDAQ rose 0.28% to 11,65

U.S. stocks turned higher midway through trading as investors digested the recent jobs report for the month of June. The Dow traded up 0.21% to 31,450.12 while the NASDAQ rose 0.21% to 11,646.33. The